In the current wave of booming global pharmaceutical industry, WuXi AppTec is taking a pioneering stance and injecting strong momentum for sustainable development into the pharmaceutical supply chain with its comprehensive ESG strategy, leading the industry towards a new era of green and efficient development.
As a leading global pharmaceutical research and development service enterprise, WuXi AppTec has integrated sustainable development into its core development strategy since 2020. Based on the United Nations Sustainable Development Goals (SDGs), it has formulated a comprehensive ESG strategy of "assisting global partners in developing more new and good drugs through an integrated empowerment platform, benefiting global patients; and working together with all sectors to promote social and environmental sustainability through responsible operations". This strategy is not an empty slogan, but a tangible implementation in every aspect of enterprise operations.
In terms of supply chain management, WuXi AppTec cleverly integrates ESG factors into the risk identification process, regularly conducts targeted ESG risk assessments, and greatly enhances supply chain stability. In 2023, facing rigorous scrutiny from global customers, regulatory agencies, and independent third parties, WuXi AppTec has undergone 748 quality audits and 83 information security audits, all of which are 100% compliant with requirements and have no significant findings, winning global trust with excellent quality.
Not only that, WuXi AppTec has also demonstrated outstanding responsibility in addressing climate change. The company solemnly promises to reduce energy consumption intensity and carbon emission intensity by 25% and water intensity by 30% respectively compared to 2020 by 2030, and actively participate in the Scientific Carbon Target Initiative (SBTi). The Swiss Kuwei base under its umbrella has achieved outstanding results in reducing carbon emissions by 70% compared to before, by installing double-layer glass curtain walls and automatic blinds, intelligently adjusting indoor temperature using natural light and external temperature, and utilizing advanced measures such as solar panels and high-efficiency dry-type transformers.
WuXi AppTec continues to cultivate its "technical expertise", and its continuous production technology has supported over 100 customers and more than 300 projects worldwide, reducing waste emissions by over 1000 tons; The integrated enzyme catalytic platform technology has assisted over 40 customers and more than 70 projects, effectively reducing the use of organic solvents by about 1700 tons, significantly shortening reaction steps, improving reaction yields, and achieving green research and development production from the root, driving overall optimization and upgrading of the industrial chain upstream and downstream.
WuXi AppTec adheres to long-term principles and steadily advances on the path of ESG. With an extreme pursuit of operational details, it not only helps partners accelerate the emergence of breakthrough therapies, but also sets an example for the sustainable development of the global pharmaceutical supply chain, achieving harmony and win-win between enterprises and society, and continuously contributing to the global health industry.
